Signal active
Organization
Contact Information
Overview
Paradigm is rebuilding the clinical research ecosystem by developing a platform that allows all patients equitable access to trials while improving trial efficiency and lowering barriers to participation for healthcare providers. It is an innovative company that is dedicated to transforming the clinical research ecosystem. Their mission is to create a more accessible and equitable healthcare system by developing a platform that enables patients from diverse backgrounds to participate in clinical trials.
Clinical trials are essential for testing and developing new drugs, therapies, and medical devices, but historically, they have been plagued by inefficiencies, barriers to access, and inequities in patient representation. Paradigm aims to solve these challenges by creating a platform that uses technology and data-driven insights to streamline the clinical trial process, making it more efficient, cost-effective, and inclusive.
The Paradigm platform is designed to facilitate seamless communication and collaboration among all stakeholders involved in clinical research, including patients, healthcare providers, pharmaceutical companies, and regulatory agencies. By leveraging technology such as AI, machine learning, and predictive analytics, Paradigm can identify and match eligible patients to clinical trials, streamline the recruitment and enrollment process, and provide real-time data insights to all stakeholders.
Overall, Paradigm's innovative approach to clinical research has the potential to revolutionize the healthcare industry by improving patient outcomes, reducing healthcare costs, and accelerating the development of new treatments and therapies.
About
Life Science, Health Care, Hospital, Health Diagnostics
2021
101-250
Headquarters locations
New York, New York, United States, North America
Social
N/A
Profile Resume
Paradigm headquartered in New York, New York, United States, North America, operates in the Life Science, Health Care, Hospital, Health Diagnostics sector. The company focuses on Life Science and has secured $3.2B in funding across 16 round(s). With a team of 101-250 employees, Paradigm is actively contributing to advancements in Life Science. Their latest funding round, Series A - Paradigm, raised $203.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
1
8
0
$203.0M
Details
1
Paradigm has raised a total of $203.0M in funding over 1 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2023 | Early Stage Venture | 203.0M |
Investors
Paradigm is funded by 17 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
Hemant Taneja | - | FUNDING ROUND - Hemant Taneja | 203.0M |
Paradigm | - | FUNDING ROUND - Paradigm | 203.0M |
General Catalyst | - | FUNDING ROUND - General Catalyst | 203.0M |
Paradigm | - | FUNDING ROUND - Paradigm | 203.0M |
Recent Activity
There is no recent news or activity for this profile.